Is Opko Health Inc (OPK) overvalued? · rev $183.6M
Opko Health Inc (OPK) is a diagnostics & research company listed on US.
This page asks whether Opko Health Inc (OPK) looks expensive on cached numbers — not a short thesis.
Latest reported OPK revenue for 2024-12-31 was $183.6M. Net income was $14.0M. Revenue was up 5.8% from 2024-09-30 to 2024-12-31. OPK currently screens at market cap $1.07B.
OPK currently screens at market cap $1.07B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next OPK 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the OPK stock page for the full model, not this heading.
Not investment advice.